Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma.

Seidl H, Richtig E, Tilz H, Stefan M, Schmidbauer U, Asslaber M, Zatloukal K, Herlyn M, Schaider H.

Hum Pathol. 2007 May;38(5):768-80. Epub 2007 Feb 15.

PMID:
17306330
2.
3.

Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.

Deutsch AJ, Aigelsreiter A, Steinbauer E, Frühwirth M, Kerl H, Beham-Schmid C, Schaider H, Neumeister P.

J Pathol. 2008 Aug;215(4):431-44. doi: 10.1002/path.2372.

PMID:
18561120
4.

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS.

Clin Cancer Res. 2004 Apr 1;10(7):2351-8.

5.

Loss of EphB6 expression in metastatic melanoma.

Hafner C, Bataille F, Meyer S, Becker B, Roesch A, Landthaler M, Vogt T.

Int J Oncol. 2003 Dec;23(6):1553-9.

PMID:
14612926
6.

The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.

Hu J, Deng X, Bian X, Li G, Tong Y, Li Y, Wang Q, Xin R, He X, Zhou G, Xie P, Li Y, Wang JM, Cao Y.

Clin Cancer Res. 2005 Jul 1;11(13):4658-65.

7.

Human melanoma metastases express functional CXCR4.

Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G.

Clin Cancer Res. 2006 Apr 15;12(8):2427-33.

8.

[Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials].

Xue TC, Chen RX, Ye SL, Sun RX, Chen J, Tang ZY.

Zhonghua Gan Zang Bing Za Zhi. 2007 Apr;15(4):261-5. Chinese.

PMID:
17456312
9.

Differential expression of chemokine receptors on uveal melanoma cells and their metastases.

Li H, Alizadeh H, Niederkorn JY.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):636-43. doi: 10.1167/iovs.07-1035.

PMID:
18235009
10.

CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.

Monteagudo C, Ramos D, Pellín-Carcelén A, Gil R, Callaghan RC, Martín JM, Alonso V, Murgui A, Navarro L, Calabuig S, López-Guerrero JA, Jordá E, Pellín A.

Clin Exp Metastasis. 2012 Aug;29(6):625-37. doi: 10.1007/s10585-012-9476-2. Epub 2012 Apr 21.

PMID:
22526457
11.

Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.

Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O.

J Immunol. 2003 Feb 1;170(3):1136-40.

12.

Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma.

Harasawa H, Yamada Y, Hieshima K, Jin Z, Nakayama T, Yoshie O, Shimizu K, Hasegawa H, Hayashi T, Imaizumi Y, Ikeda S, Soda H, Soda H, Atogami S, Takasaki Y, Tsukasaki K, Tomonaga M, Murata K, Sugahara K, Tsuruda K, Kamihira S.

Leuk Lymphoma. 2006 Oct;47(10):2163-73.

PMID:
17071491
13.

Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.

López-Giral S, Quintana NE, Cabrerizo M, Alfonso-Pérez M, Sala-Valdés M, De Soria VG, Fernández-Rañada JM, Fernández-Ruiz E, Muñoz C.

J Leukoc Biol. 2004 Aug;76(2):462-71. Epub 2004 May 20.

14.

Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.

Massi D, Naldini A, Ardinghi C, Carraro F, Franchi A, Paglierani M, Tarantini F, Ketabchi S, Cirino G, Hollenberg MD, Geppetti P, Santucci M.

Hum Pathol. 2005 Jun;36(6):676-85.

PMID:
16021575
15.

Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.

Becker B, Multhoff G, Farkas B, Wild PJ, Landthaler M, Stolz W, Vogt T.

Exp Dermatol. 2004 Jan;13(1):27-32.

PMID:
15009113
16.

Widespread expression of parathyroid hormone-related peptide in melanocytic cells.

Kageshita T, Ishihara T, Tokuo H, Funasaka Y, Ichihashi M, Dong J, Nakajima M, Ono T.

Br J Dermatol. 2003 Mar;148(3):533-8.

PMID:
12653746
17.

Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?

Kühnelt-Leddihn L, Müller H, Eisendle K, Zelger B, Weinlich G.

Arch Dermatol Res. 2012 Apr;304(3):185-93. doi: 10.1007/s00403-012-1222-8. Epub 2012 Feb 17.

PMID:
22350183
18.

Loss of p14ARF expression in melanoma.

Dobrowolski R, Hein R, Buettner R, Bosserhoff AK.

Arch Dermatol Res. 2002 Jan;293(11):545-51.

PMID:
11876522
19.

Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia.

Lin S, Sun L, Hu J, Wan S, Zhao R, Yuan S, Zhang L.

Cancer Lett. 2009 Jun 28;279(1):108-17. doi: 10.1016/j.canlet.2009.01.029. Epub 2009 Feb 23.

PMID:
19231068
20.

Lymphotoxin gene expression by melanocytes and melanoma cell lines and persistence of unspliced mRNA.

Melani C, Silvani A, Parmiani G, Colombo MP.

FEBS Lett. 1993 Nov 29;335(1):114-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk